These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
334 related items for PubMed ID: 11708927
1. A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline. Davioud-Charvet E, Delarue S, Biot C, Schwöbel B, Boehme CC, Müssigbrodt A, Maes L, Sergheraert C, Grellier P, Schirmer RH, Becker K. J Med Chem; 2001 Nov 22; 44(24):4268-76. PubMed ID: 11708927 [Abstract] [Full Text] [Related]
2. Double-drug development against antioxidant enzymes from Plasmodium falciparum. Biot C, Dessolin J, Grellier P, Davioud-Charvet E. Redox Rep; 2003 Nov 22; 8(5):280-3. PubMed ID: 14962365 [Abstract] [Full Text] [Related]
5. Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum. Friebolin W, Jannack B, Wenzel N, Furrer J, Oeser T, Sanchez CP, Lanzer M, Yardley V, Becker K, Davioud-Charvet E. J Med Chem; 2008 Mar 13; 51(5):1260-77. PubMed ID: 18260613 [Abstract] [Full Text] [Related]
6. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo. Soares RR, da Silva JM, Carlos BC, da Fonseca CC, de Souza LS, Lopes FV, de Paula Dias RM, Moreira PO, Abramo C, Viana GH, de Pila Varotti F, da Silva AD, Scopel KK. Bioorg Med Chem Lett; 2015 Jun 01; 25(11):2308-13. PubMed ID: 25920564 [Abstract] [Full Text] [Related]
10. New 4-aminoquinoline Mannich base antimalarials. 1. Effect of an alkyl substituent in the 5'-position of the 4'-hydroxyanilino side chain. Raynes KJ, Stocks PA, O'Neill PM, Park BK, Ward SA. J Med Chem; 1999 Jul 29; 42(15):2747-51. PubMed ID: 10425085 [Abstract] [Full Text] [Related]
15. Design, synthesis and in vitro antiplasmodial activity of some bisquinolines against chloroquine-resistant strain. Kondaparla S, Agarwal P, Srivastava K, Puri SK, Katti SB. Chem Biol Drug Des; 2017 Jun 29; 89(6):901-906. PubMed ID: 27896925 [Abstract] [Full Text] [Related]
16. Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro. Sáenz FE, Mutka T, Udenze K, Oduola AM, Kyle DE. Antimicrob Agents Chemother; 2012 Sep 29; 56(9):4685-92. PubMed ID: 22710117 [Abstract] [Full Text] [Related]
18. Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases. Warhurst DC, Craig JC, Adagu IS, Guy RK, Madrid PB, Fivelman QL. Biochem Pharmacol; 2007 Jun 15; 73(12):1910-26. PubMed ID: 17466277 [Abstract] [Full Text] [Related]
19. Plasmodium berghei: implication of intracellular glutathione and its related enzyme in chloroquine resistance in vivo. Dubois VL, Platel DF, Pauly G, Tribouley-Duret J. Exp Parasitol; 1995 Aug 15; 81(1):117-24. PubMed ID: 7628559 [Abstract] [Full Text] [Related]
20. Piperaquine and Lumefantrine resistance in Plasmodium berghei ANKA associated with increased expression of Ca2+/H+ antiporter and glutathione associated enzymes. Kiboi D, Irungu B, Orwa J, Kamau L, Ochola-Oyier LI, Ngángá J, Nzila A. Exp Parasitol; 2014 Dec 15; 147():23-32. PubMed ID: 25448357 [Abstract] [Full Text] [Related] Page: [Next] [New Search]